Opportunity

Federal Register #2026-16716

FDA Notice: OMB Approval of Regulatory Information Collection Activities

Buyer

Food and Drug Administration

Posted

August 17, 2026

Identifier

2026-16716

The Food and Drug Administration (FDA), part of the Department of Health and Human Services, has published an informational notice regarding regulatory paperwork requirements: - No procurement or award is being made; this is not a solicitation for products or services - FDA lists information collection activities approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act - Covers a range of regulatory requirements, including: - Drug registration - Medical device reporting - Manufacturing practices - Third-party disclosure and recordkeeping for reportable food - Provides OMB control numbers and expiration dates for each collection - Invites public comment on proposed information collection activities - No OEMs, vendors, products, or services are mentioned or requested - Notice is strictly informational, outlining compliance and paperwork requirements for regulated entities

Description

The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. This notice includes details about various FDA information collections recently approved by OMB, covering topics such as drug registration, medical device reporting, and other regulatory requirements. The announcement provides information on the OMB control numbers and expiration dates for each collection. It serves to inform the public and stakeholders about the approved information collection activities and invites comments on related matters.

View original listing